Research & Innovation

The American Alternative Care Policy Network has launched its Veterans Equal Access Initiative and formally endorsed federal legislation that would restore equal healthcare access for veterans by allowing VA physicians to discuss and recommend medical cannabis where permitted by state law.

The U.S. Department of Health and Human Services and the Department of Veterans Affairs have announced a landmark partnership to accelerate research and implementation of rapid-acting mental health treatments for veterans, including psychedelic-assisted therapies. Read the official federal announcement below.

Originally published in the Hartford Courant, this op-ed examines Connecticut's Public Act 26-108 and its implications for psychedelic-assisted therapy, evidence-based healthcare innovation, and patient access.

New VA Trial of MDMA Psychedelic for PTSD

As a healthcare professional working directly with patients, Jonathan "Gio" Stelly argues that Congress should delay the November 12 restrictions on hemp-derived THC beverages and instead pursue a regulatory framework grounded in science, consumer safety, and patient access.

Starting July 1, CT medical program using psychedelics opens to the public.

New discoveries are reshaping scientific understanding of psychedelic compounds and their potential role in treating mental health conditions. The Atlantic explores the research driving this rapidly evolving field.

Oregon’s psilocybin services program offers an early case study for states considering how to expand access to psychedelics while maintaining responsible safety protections.

The American Alternative Care Policy Network (AACPN) has announced a national policy agenda focused on expanding access to evidence-based integrative and alternative healthcare. Through its Alternative Care Access Campaign, Psychedelic Research Initiative, and Hemp Beverage Policy Initiative, AACPN seeks to advance healthcare access, scientific research, patient choice, and evidence-based policy for veterans, trauma survivors, first responders, and other underserved populatio

Millions of Americans—including veterans, first responders, seniors, and trauma survivors—face barriers accessing treatments that may improve their quality of life because insurance coverage has not kept pace with scientific research. AACPN's Alternative Care Access Campaign advocates for Medicare, Medicaid, VA, and private insurance policies that incorporate evidence-based alternative and integrative healthcare treatments shown to be safe, effective, and beneficial to patien

AACPN is calling for expanded scientific research into psychedelic-assisted therapies as potential trauma treatment options for survivors of sexual violence. The organization says survivors deserve compassionate, evidence-based care and continued research into emerging mental health therapies including MDMA, psilocybin, and ketamine-assisted treatment.

The American Alternative Care Policy Network (AACPN) this week launched its Psychedelic Research Initiative to support continued scientific research into emerging therapies that may help address some of America's most difficult mental health challenges. At the center of this effort are veterans. For many veterans, the invisible wounds of service can persist long after they return home. Post-traumatic stress, depression, anxiety, traumatic brain injury, substance-use disorders

AACPN applauds Connecticut’s enactment of Public Act 26-108, expanding the state’s psychedelic-assisted therapy pilot program and supporting continued clinical research involving MDMA and psilocybin therapies for veterans, first responders, trauma survivors, and individuals living with treatment-resistant mental health conditions.

The U.S. Department of Veterans Affairs has launched a new MDMA-assisted therapy clinical trial focused on veterans with PTSD and trauma-related conditions. The initiative reflects growing interest in evidence-based psychedelic-assisted therapies and broader efforts to expand innovative mental health treatment options for veterans and other trauma survivors.